These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32589563)

  • 1. Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study.
    Subbalaxmi MVS; Soanker R; Lakshmi AV
    Curr Drug Saf; 2020; 15(3):198-204. PubMed ID: 32589563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel risk factors and early detection of anti tubercular treatment induced liver injury-Looking beyond American Thoracic Society Guidelines.
    Latief M; Dar WR; Sofi N; Dar IA; Kasana B; Hussain M; Arshad F; Shah BA; Koul PA
    Indian J Tuberc; 2017 Jan; 64(1):26-32. PubMed ID: 28166913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring and management of antituberculosis drug induced hepatotoxicity.
    Agal S; Baijal R; Pramanik S; Patel N; Gupte P; Kamani P; Amarapurkar D
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1745-52. PubMed ID: 16246196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.
    Indumathi CK; Sethuraman A; Jain S; Krishnamurthy S
    Indian J Pediatr; 2019 Mar; 86(3):229-232. PubMed ID: 30515702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India.
    Saha A; Shanthi F X M; Winston A B; Das S; Kumar A; Michael JS; Balamugesh T
    J Prim Care Community Health; 2016 Jul; 7(3):171-4. PubMed ID: 27056794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of and risk factors related to hepatotoxicity during tuberculosis treatment.
    Babalık A; Arda H; Bakırcı N; Ağca S; Oruç K; Kızıltaş S; Cetintaş G; Calışır HC
    Tuberk Toraks; 2012; 60(2):136-44. PubMed ID: 22779934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
    Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S
    Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting antitubercular drug-induced liver injury and its outcome and introducing a novel scoring system.
    Raj Mani SS; Iyyadurai R; Mishra AK; Manjunath K; Prasad J; Lakshmanan J; Yadav B; Reginald A; Jasmine S; Hansdak SG; Zachariah A
    Int J Mycobacteriol; 2021; 10(2):116-121. PubMed ID: 34558461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity Due to Antituberculosis Therapy among Paediatric Patients Seen at the University of Ilorin Teaching Hospital, North Central Nigeria.
    Aishatu G; Rasheedah I; Wahab J; Sheni M; Damilola O; Adeniyi O
    Ethiop J Health Sci; 2017 Mar; 27(2):115-120. PubMed ID: 28579706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malnutrition as an important risk factor for drug-induced liver injury in patients on anti-tubercular therapy: an experience from a tertiary care center in South India.
    Ali N; Gupta N; Saravu K
    Drug Discov Ther; 2020; 14(3):135-138. PubMed ID: 32669522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
    Isa SE; Ebonyi AO; Shehu NY; Idoko P; Anejo-Okopi JA; Simji G; Odesanya RU; Abah IO; Jimoh HO
    Int J Mycobacteriol; 2016 Mar; 5(1):21-6. PubMed ID: 26927986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective survey of drug induced hepatotoxicity in a large hospital.
    Kshirsagar NA; Karande SC; Potkar CN
    Indian J Gastroenterol; 1992 Jan; 11(1):13-5. PubMed ID: 1551705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti-HCV a risk factor?
    Nader LA; de Mattos AA; Picon PD; Bassanesi SL; De Mattos AZ; Pineiro Rodriguez M
    Ann Hepatol; 2010; 9(1):70-4. PubMed ID: 20308724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naïve patients with pulmonary tuberculosis: A randomized, comparative study.
    Hasanain AFA; Zayed AAH; Mahdy RE; Nafee AMA
    Int J Mycobacteriol; 2017; 6(2):149-155. PubMed ID: 28559516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.
    Ngongondo M; Miyahara S; Hughes MD; Sun X; Bisson GP; Gupta A; Kumwenda J; Lavenberg JA; Torres TS; Nyirenda M; Kidonge KK; Hosseinipour MC;
    J Acquir Immune Defic Syndr; 2018 May; 78(1):54-61. PubMed ID: 29406428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy.
    Mansukhani S; Shah I
    Ann Hepatol; 2012; 11(1):96-9. PubMed ID: 22166567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.
    McNeill L; Allen M; Estrada C; Cook P
    Chest; 2003 Jan; 123(1):102-6. PubMed ID: 12527609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre.
    Shu CC; Lee CH; Lee MC; Wang JY; Yu CJ; Lee LN
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):934-9. PubMed ID: 23743313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.